Intracameral bevacizumab for treatment of iris rubeosis
- VernacularTitle:前房注射Bevacizumab治疗虹膜红变的疗效观察
- Author:
Tao, LIU
- Publication Type:Journal Article
- Keywords:
intracameral;
iris rubeosis:Bevacizumab(Avastin)
- From:
International Eye Science
2008;8(9):1761-1763
- CountryChina
- Language:Chinese
-
Abstract:
AIM:.To report the curative effect and safty of intracameral bevacizumab(avastin)in patients with rubeosis iridis.METHODS:5 cases(5 eyes)with iris rubeosis secondary to diabetic retinopathy,retinal periphlebitis(Eales disease)and branch/central retinal vein occlusion,among which 2 cases were silicon oil eyes and were performed intracameral bevacizumab(avastin)0.03 cc(0.75mg),one case is combined with trabeculectomy.and another with cyclocryosurgery.RESULTS:The rubeosis of all cases disappeared quickly,meanwhile the intraocular pressure decreased to normal range with the help of anti-glaucoma operation and medicine.There are not any sign of rubeosis again in the 2-5 months follow-up visits and intraocular pressure were well-controlled.CONCLUSION:Intracameral bevacizumab(avastin)was an effective treatment for rubeosis,esp,for some cases that can not be injected to vitreous cavity.Short term study of intracameral bevacizumab demonstrated rapid regression of rubeosis and well-tolerated injection with no obvious side effects.
